WEIGAO GROUP Repurchases 100,000 H Shares at HKD 3.22; Treasury Stock Climbs to 60.30 Million

Bulletin Express07-06

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a next-day return confirming the on-market repurchase of 100,000 H shares on 6 July 2026. The shares were bought at prices between HKD 3.21 and HKD 3.22, with a volume-weighted average cost of HKD 3.218 per share, for a total consideration of HKD 0.32 million.

Following the transaction: • Issued share capital (excluding treasury shares) decreased marginally to 4,462.03 million shares, down 0.0022% from 4,462.13 million. • Treasury share holdings rose to 60.30 million shares. • Total issued shares, including treasury stock, remained unchanged at 4,522.33 million.

The buyback forms part of the mandate approved by shareholders on 29 May 2026, which authorises the company to repurchase up to 446.46 million shares. Cumulative repurchases under this mandate have reached 2.98 million shares, representing 0.67% of the shares outstanding at the mandate date. In line with Hong Kong Stock Exchange rules, WEIGAO GROUP is subject to a moratorium on issuing, selling or transferring shares until 5 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment